| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.29 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |